Recently added

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

Thunold, Solfrid; Hernes, Eivor; Farooqi, Saima ; Francis, Roslyn; Simo Perdigo, Marc; Öjlert, Åsa Kristina; Nowak, Anna; cedres, susana (Springer, 2025-01)

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Gillessen, Silke; Turco, Fabio; Davis, Ian; Fizazi, Karim; James, Nicholas; Efstathiou, Jason; Mateo, Joaquin (Elsevier, 2025-02)

International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease

Giani, Claudia; Salawu, Abdulazeez; Ljevar, Silva; Denu, Ryan; Napolitano, Andrea; Palmerini, Emanuela; Cicala, Carlo Maria (Wolters Kluwer Health, 2025-01)

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI

Macarro, Carlos; Bernatowicz, Kinga; García Ruiz, Alonso; Monreal-Agüero, Camilo; Corral Gámez, Juanfra; Merino Casabiel, Xavier; Mast, Richard; Serna, Garazi; Simonetti, Sara; Roson Gradaille, Nuria; Vieito , Maria; ESCOBAR, MANUEL; Toledo, Rodrigo; Nuciforo, Paolo; GARRALDA, Elena; Perez-Lopez, Raquel; Grussu, Francesco (Wiley, 2025-02)

Converging and evolving immuno-genomic routes toward immune escape in breast cancer

Blanco Heredia, Juan; Anjos-Souza, Carla; Trincado Alonso, Juan Luis; Gonçalves-Ribeiro, Samuel; Ruiz Gil, Sara; Gonzalez-Cao, Maria (Nature Portfolio, 2024-02-21)

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI

Converging and evolving immuno-genomic routes toward immune escape in breast cancer

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine ﻿

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC) ﻿

International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease ﻿

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI ﻿

Converging and evolving immuno-genomic routes toward immune escape in breast cancer ﻿

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease

Enhancing Tumor Microstructural Quantification With Machine Learning and Diffusion-Relaxation MRI

Converging and evolving immuno-genomic routes toward immune escape in breast cancer